Join us for a webinar on the most urgent international logistics challenges and issues facing life science companies today, especially regarding US-China interactions, future trends, and recommendations for life science leaders.

US life science companies face ongoing trade and logistical challenges to develop and produce their drug products in the global market. Issues include:

• Growing reliance on internationally manufactured API, particularly from China
• Increased regulatory and safety considerations
• National security considerations
• Global ocean and air freight considerations

Adding to the complexity, governments are increasingly using global trade as a component of their foreign policy. Those policy decisions may be out of industry control, but they have significant ramifications on life science supply chains. Right now, this is most notable in the volatile dynamic between the US and China.

Speakers

Todd Applebaum
Managing Director, Converge Consulting

Todd Applebaum is an expert in business strategy, operations, manufacturing and supply chain management, working throughout the Life Sciences spectrum, including the pharmaceutical, biologics and medical device sectors. As Managing Director, he leads Converge and provides senior leadership for many of the firm’s complex projects. Prior to founding Converge, Applebaum served as VP, Technical Operations at Ovascience, leading Manufacturing, Quality, Supply Chain, and Technical Services as the company transitioned to commercial operations. He also served as the VP of Research, Healthcare and Life Science at Gartner, where he provided strategic insights to executives, analyzed best practices and authored research reports on industry trends including building patient outcomes-focused operations, the impact of personalized and precision medicines, global planning, track & trace technologies, and operational & performance excellence. He has an MBA from Carnegie Mellon University and a BS in Industrial Engineering from General Motors Institute.

Mile Iliev
Senior Consultant, Converge Consulting

Mile Iliev has a background in clinical and commercial supply chain, operations, project management, data analytics, and financial management. Currently, Iliev provides engagement management for emerging and established biopharmaceutical clients dealing with Supply Chain and Logistics challenges. Prior to Converge, he served as an advisor with a private health and lifestyle company, analyzing sales data and developing strategic insights using their in-house mobile platform. Iliev has also conducted extensive market research, competitor analysis, and cost analyses to develop a dynamic 3-statement financial performance model, using the model to provide financial leverage recommendations and evaluate both new business opportunities and strategic partnerships. He earned his MBA at Babson College and holds a B.S. in International Economy and Business from St. Kliment Ohridski University in Prilep, Macedonia. Iliev is proficient in Spanish, Serbo-Croatian and Bulgarian.